Sharing Unexpected Biomarker Results with Study Participants

被引:23
作者
Hernick, Ann D. [1 ]
Brown, M. Kathryn [2 ]
Pinney, Susan M. [2 ]
Biro, Frank M. [3 ]
Ball, Kathleen M. [1 ]
Bornschein, Robert L. [2 ]
机构
[1] Breast Canc Alliance Greater Cincinnati, Cincinnati, OH USA
[2] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA
[3] Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH USA
基金
美国国家卫生研究院;
关键词
biomarkers; children; communication; environmental exposures; PFOA; research ethics; transdisciplinary research; HEALTH; EXPOSURE; RISK;
D O I
10.1289/ehp.1001988
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
BACKGROUND: The Breast Cancer and the Environment Research Centers (BCERCs) include collaborators from basic sciences, epidemiology, and the community, conducting studies to investigate whether environmental exposures are associated with the timing of puberty. A pilot study of a subset of the study participants assessed the feasibility of measuring selected biomarkers of exposure in blood and urine in girls 6-8 years of age. In the Greater Cincinnati study population, we found an elevated serum concentration of perfluorooctanoate (PFOA) among > 90% of young girls living in a small community. OBJECTIVES: The research team deliberated whether and how to report the PFOA findings to our study families. We will address the issues considered in our decision, as well as the formats we used to present the findings. METHODS: The results were verified as we searched for potential sources of the elevated PFOA levels. As a research team, we grappled with issues regarding the reporting of unexpected results, derived from unknown sources and with unknown clinical significance. Ultimately, we did decide to present these findings to the study families through a well-developed communication plan. DISCUSSION: Research team members came from a variety of experiences and backgrounds, which led to different interpretations about the clinical, ethical, and public health issues surrounding these findings. The ethical debates centered around the precautionary principle, the right to know, and do no harm. CONCLUSIONS: Given advances in environmental biomarker technologies and greater use of the transdisciplinary research model, a communication plan must be developed for those involved as study participants.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 50 条
  • [21] The association between sharing something difficult on social media and mental well-being among adolescents. Results from the "LifeOnSoMe"-study
    Kysnes, Bjarte
    Hjetland, Gunnhild Johnsen
    Haug, Ellen
    Holsen, Ingrid
    Skogen, Jens Christoffer
    FRONTIERS IN PSYCHOLOGY, 2022, 13
  • [22] Investigating the performance of 24-h urinary sucrose and fructose as a biomarker of total sugars intake in US participants - a controlled feeding study
    Tasevska, Natasha
    Sagi-Kiss, Virag
    Palma-Duran, Susana A.
    Barrett, Brian
    Chaloux, Matthew
    Commins, John
    O'Brien, Diane M.
    Johnston, Carol S.
    Midthune, Douglas
    Kipnis, Victor
    Freedman, Laurence S.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2021, 114 (02) : 721 - 730
  • [23] Sharing Qualitative Interview Data in Dialogue with Research Participants
    Kvale L.H.
    Pharo N.
    Darch P.
    Proceedings of the Association for Information Science and Technology, 2023, 60 (01) : 223 - 232
  • [24] Communicating unexpected pharmacogenomic results to biobank contributors: A focus group study
    Meagher, Karen M.
    Curtis, Susan H.
    Borucki, Sarah
    Beck, Annika
    Srinivasan, Tarika
    Cheema, Amal
    Sharp, Richard R.
    PATIENT EDUCATION AND COUNSELING, 2021, 104 (02) : 242 - 249
  • [25] Engaging study participants in interpreting results: lessons from the TRIO study in Kenya and South Africa
    Agot, Kawango
    Minnis, Alexandra M.
    Manenzhe, Kgahlisho
    Browne, Erica N.
    Ahmed, Khatija
    Okello, Timothy
    van der Straten, Ariane
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2019, 11 : 395 - 403
  • [26] Disclosure of research results: a randomized study on GENEPSO-PS cohort participants
    Mancini, Julien
    Le Cozannet, Elodie
    Bouhnik, Anne-Deborah
    Resseguier, Noemie
    Lasset, Christine
    Mouret-Fourme, Emmanuelle
    Nogues, Catherine
    Julian-Reynier, Claire
    HEALTH EXPECTATIONS, 2016, 19 (05) : 1023 - 1035
  • [27] THE COMMUNICATION OF PHARMACOGENETIC RESEARCH RESULTS: PARTICIPANTS WEIGH IN ON THEIR INFORMATIONAL NEEDS IN A PILOT STUDY
    Madadi, Parvaz
    Joly, Yann
    Avard, Denise
    Chitayat, David C.
    Smith, M. Anne
    Ross, Colin J. D.
    Carleton, Bruce C.
    Hayden, Michael R.
    Koren, Gideon
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2011, 18 (01): : E152 - E155
  • [28] Disseminating clinical study results to trial participants in Ethiopia: insights and lessons learned
    Degaga, Tamiru S.
    Weston, Sophie
    Tego, Tedla T.
    Abate, Dagimawie T.
    Aseffa, Ashenafi
    Wayessa, Adugna
    Price, Ric N.
    Hailu, Asrat
    Thriemer, Kamala
    MALARIA JOURNAL, 2020, 19 (01)
  • [29] Underreporting of non-study cigarette use by study participants confounds the interpretation of results from ambulatory clinical trial of reduced nicotine cigarettes
    Zhang, Mingda
    Wang, Jingzhu
    Edmiston, Jeffery
    HARM REDUCTION JOURNAL, 2024, 21 (01)
  • [30] Genomic research and wide data sharing: Views of prospective participants
    Trinidad, Susan Brown
    Fullerton, Stephanie M.
    Bares, Julie M.
    Jarvik, Gail P.
    Larson, Eric B.
    Burke, Wylie
    GENETICS IN MEDICINE, 2010, 12 (08) : 486 - 495